Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (991-1000 of 1,467) with videos related to

Pageof 147
Sort By:
Plos One|July 19, 2017
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupusHarald Leiss, Wilhelm Salzberger, Barbara Jacobs, et al.
Annals of the Rheumatic Diseases|October 1, 2013
Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cellsStephan Blüml, Martin Friedrich, Tobias Lohmeyer, et al.
Lancet (London, England)|October 31, 2013
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trialJosef S Smolen, Paul Emery, Roy Fleischmann, et al.
Behavior Genetics|November 8, 2014
The National Longitudinal Study of Adolescent to Adult Health (Add Health) sibling pairs genome-wide dataMatthew B McQueen, Jason D Boardman, Benjamin W Domingue, et al.
The American Journal of the Medical Sciences|April 1, 1985
Systemic lupus erythematosus: delineation of subpopulations by clinical, serologic, and T cell subset analysisJ S Smolen, C Morimoto, A D Steinberg, et al.
Annals of the Rheumatic Diseases|January 9, 2014
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Sofia Ramiro, Cecile Gaujoux-Viala, et al.
The Journal of Rheumatology|August 4, 2005
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritisJoachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, et al.
Arthritis and Rheumatism|April 29, 2008
Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and HealthBirgit Prodinger, Alarcos Cieza, David A Williams, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Characterization and analysis of the proximal Janus kinase 3 promoterMartin Aringer, Sigrun R Hofmann, David M Frucht, et al.
Pageof 147

Showing results (991-1000 of 1,467) with videos related to

Sort By:
Pageof 147
Plos One|July 19, 2017
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupusHarald Leiss, Wilhelm Salzberger, Barbara Jacobs, et al.
Annals of the Rheumatic Diseases|October 1, 2013
Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cellsStephan Blüml, Martin Friedrich, Tobias Lohmeyer, et al.
Lancet (London, England)|October 31, 2013
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trialJosef S Smolen, Paul Emery, Roy Fleischmann, et al.
Behavior Genetics|November 8, 2014
The National Longitudinal Study of Adolescent to Adult Health (Add Health) sibling pairs genome-wide dataMatthew B McQueen, Jason D Boardman, Benjamin W Domingue, et al.
The American Journal of the Medical Sciences|April 1, 1985
Systemic lupus erythematosus: delineation of subpopulations by clinical, serologic, and T cell subset analysisJ S Smolen, C Morimoto, A D Steinberg, et al.
Annals of the Rheumatic Diseases|January 9, 2014
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Sofia Ramiro, Cecile Gaujoux-Viala, et al.
The Journal of Rheumatology|August 4, 2005
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritisJoachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, et al.
Arthritis and Rheumatism|April 29, 2008
Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and HealthBirgit Prodinger, Alarcos Cieza, David A Williams, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Characterization and analysis of the proximal Janus kinase 3 promoterMartin Aringer, Sigrun R Hofmann, David M Frucht, et al.
Pageof 147